5:47 PM
 | 
Jun 04, 2012
 |  BC Extra  |  Company News

Astellas, Drais form newco to develop Astellas' IBS product

Astellas Pharma Inc. (Tokyo:4503) and Drais Pharmaceuticals Inc. (Bridgewater, N.J.) partnered to form virtual company -- Seldar Pharma Inc. -- that will develop and commercialize Astellas' ASP7147 for irritable bowel syndrome with...

Read the full 151 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >